Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of direct acting anti-viral agents (DAA) therapy in
chronically infected Hepatitis C Virus (HCV) patients using an individualized response guided
therapy (RGT) model.
Phase:
N/A
Details
Lead Sponsor:
Soroka University Medical Center
Collaborator:
Loyola University, Harel Dahari, PhD, mathematical modeling support